VivoSeq
Explore
Companies
Drugs
Sign In
Report Error
FOLFOX4 .
Preclinical
Small molecule
E
Eastern Hepatobiliary Surgery Hospital
1
Indications
1
Total Trials
0
Active Trials
0
Competitors
Pipeline
Status by Indication
[3]
[1]
Indication
Preclinical
Phase 1
Phase 2
Phase 3
Approved
Circulating Tumor Cells
Unknown status
Preclinical
Phase 1
Phase 2
Phase 3
Approved
Circulating Tumor Cells
Preclinical
Unknown status
Clinical
Trials by Indication
[1]
Circulating Tumor Cells
1 trial
A Trial of Adjuvant Therapy After Hepatocarcinoma Resection Based on Folate Receptor-positive Circulating Tumor Cells
Unknown status
·
—
·
N/A
·
NCT04521491
·
184 enrolled
Sources
References
[1]
ClinicalTrials.gov
—
1 trial record for FOLFOX4 .. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL
—
FOLFOX4 . compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform
—
Drug–disease associations for FOLFOX4 .. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR
—
Eastern Hepatobiliary Surgery Hospital company filings. U.S. Securities and Exchange Commission.
Details
Drug Info
Quick Facts
Modality
Small molecule
[2]
Highest Phase
Preclinical
[1]
Company
E
Eastern Hepatobiliary Surgery Hospital
Related News